Profile data is unavailable for this security.
About the company
Borosil Scientific Limited is a manufacturer of laboratory glassware. It offers scientific and laboratory glassware, which finds application across varied disciplines, such as quality control in pharmaceutical industries, food and soil testing, microbiology, and biotechnology. Its laboratory equipment LabQuest offers a portfolio of solutions in four key application categories: nutrition and environment, life sciences, liquid handling, and an array of essential laboratory equipment. Its LabQuest products include Block Digesters, Kjeldahl Distillation, Water Baths, Hot Plate Magnetic Stirrer, Water Distillation, COD Digesters, Soxhlet Apparatus, Heating Mantles, e-Titrate, Recirculating Chillers, Shakers, Soxhlet Apparatus for Fat Estimation, Suvaccha, Vacuum Pump, Vortex Mixers, Water Baths, and Water Distillation Moisture Analyzer. It is a manufacturer of glass ampoules and tubular glass vials of USP Type, used as primary packaging materials by pharmaceutical companies.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated1991
- Employees--
- LocationBorosil Scientific LtdH - 27MUMBAI 400051IndiaIND
- Phone+91 2 267406300
- Fax+91 2 267406514
- Websitehttps://www.borosilscientific.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kopran Ltd | 6.15bn | 509.56m | 12.12bn | 394.00 | 23.94 | 2.47 | 18.98 | 1.97 | 10.50 | 10.50 | 126.95 | 101.90 | 0.8824 | 2.99 | 3.28 | -- | 7.32 | 8.47 | 10.22 | 12.23 | 34.60 | 34.18 | 8.29 | 8.89 | 1.44 | 43.23 | 0.168 | 25.41 | 11.54 | 11.42 | 87.11 | 16.23 | 12.53 | -- |
| Syncom Formulations (India) Ltd | 2.63bn | 253.14m | 12.14bn | 799.00 | 38.00 | 4.21 | 40.43 | 4.61 | 0.34 | 0.34 | 3.56 | 3.07 | 0.6732 | 7.42 | 2.95 | -- | 6.47 | 7.50 | 9.00 | 10.23 | 40.44 | 34.59 | 9.61 | 9.38 | 2.38 | 5.57 | 0.201 | -- | 17.45 | 7.12 | 26.13 | 17.95 | -- | -- |
| Lincoln Pharmaceuticals Ltd | 5.81bn | 933.05m | 13.09bn | 1.70k | 14.03 | 2.21 | 12.59 | 2.25 | 46.58 | 46.58 | 289.81 | 295.98 | 0.9017 | 3.78 | 3.90 | -- | 14.49 | 13.95 | 16.61 | 16.54 | 52.06 | 51.21 | 16.07 | 14.71 | 4.01 | 60.95 | 0.0018 | -- | 13.76 | 9.66 | 27.99 | 13.88 | 21.54 | 3.71 |
| Ngl Fine Chem Ltd | 3.39bn | 413.43m | 14.36bn | 343.00 | 34.73 | 5.47 | 27.12 | 4.24 | 66.92 | 66.92 | 548.61 | 425.11 | 1.05 | 4.51 | 4.36 | -- | 12.87 | 15.06 | 16.61 | 19.58 | 53.18 | 46.79 | 12.20 | 13.15 | 1.96 | 30.64 | 0.1218 | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
| Zota Health Care Ltd | 1.80bn | -143.48m | 15.35bn | 338.00 | -- | 16.62 | 267.19 | 8.50 | -5.59 | -5.59 | 70.40 | 34.81 | 0.9341 | 2.02 | 6.55 | -- | -7.42 | -1.38 | -10.54 | -1.85 | 46.43 | 36.48 | -7.95 | -1.33 | 0.7851 | -2.62 | 0.5143 | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
| Windlas Biotech Ltd | 6.31bn | 581.87m | 15.45bn | 1.05k | 26.45 | 3.42 | 21.56 | 2.45 | 27.94 | 27.94 | 302.99 | 216.33 | 1.09 | 5.79 | 4.99 | -- | 10.07 | -- | 13.50 | -- | 37.21 | -- | 9.22 | -- | 2.15 | 58.58 | 0.008 | -- | 22.97 | -- | 36.51 | -- | -- | -- |
| Themis Medicare Ltd | 3.82bn | 435.24m | 19.33bn | 1.54k | 44.46 | 5.12 | 34.65 | 5.06 | 4.72 | 4.72 | 41.44 | 41.03 | 0.7067 | 1.96 | 2.36 | 2,477,358.00 | 8.06 | 11.12 | 11.07 | 16.46 | 64.19 | 60.32 | 11.40 | 14.96 | 1.44 | -- | 0.2023 | 7.59 | 7.74 | 15.75 | -23.51 | -- | 26.73 | -- |
| Borosil Scientific Ltd | -100.00bn | -100.00bn | 19.55bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Sigachi Industries Ltd | 3.99bn | 571.80m | 19.67bn | 1.03k | 36.50 | 4.58 | 28.90 | 4.93 | 1.64 | 1.64 | 11.51 | 13.09 | 0.7472 | 3.19 | 3.41 | -- | 10.73 | 14.77 | 14.42 | 19.57 | 51.09 | 50.34 | 14.35 | 14.92 | 1.29 | 8.48 | 0.2552 | -- | 32.08 | 25.34 | 31.34 | 24.64 | 70.35 | -- |
| SMS Pharmaceuticals Ltd | 7.09bn | 498.26m | 20.75bn | 1.10k | 41.61 | 3.87 | 25.70 | 2.92 | 5.89 | 5.89 | 83.84 | 63.36 | 0.7413 | 2.18 | 3.69 | -- | 5.14 | 5.43 | 7.41 | 7.33 | 29.83 | 32.67 | 6.94 | 7.87 | 0.905 | 3.63 | 0.3436 | 6.59 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
| Hester Biosciences Ltd | 3.05bn | 188.89m | 20.97bn | 693.00 | 99.06 | 7.19 | 54.71 | 6.89 | 24.89 | 24.89 | 392.38 | 343.01 | 0.4572 | 1.20 | 3.85 | -- | 3.18 | 6.15 | 4.00 | 7.69 | 68.52 | 68.83 | 6.95 | 12.83 | 1.31 | 1.84 | 0.4466 | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
| Amrutanjan Health Care Ltd | 4.21bn | 449.73m | 22.59bn | 575.00 | 50.42 | 7.83 | 44.28 | 5.36 | 15.51 | 15.51 | 145.00 | 99.85 | 1.16 | 7.34 | 10.41 | -- | 12.34 | 16.22 | 15.09 | 20.12 | 49.71 | 53.30 | 10.68 | 13.23 | 3.82 | 291.99 | 0.006 | 23.37 | 10.96 | 10.71 | 12.90 | 12.46 | 26.93 | 16.43 |
| Solara Active Pharma Sciences Ltd | 13.26bn | -5.67bn | 24.34bn | 2.36k | -- | 2.45 | -- | 1.84 | -145.25 | -145.25 | 339.41 | 239.08 | 0.505 | 1.75 | 2.99 | -- | -21.60 | -2.44 | -39.08 | -3.84 | 39.28 | 43.38 | -42.77 | -4.49 | 0.3549 | -1.89 | 0.5192 | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
| IOL Chemicals and Pharmaceuticals Ltd. | 21.33bn | 1.34bn | 25.08bn | 2.56k | 18.65 | 1.56 | 12.71 | 1.18 | 22.90 | 22.90 | 363.33 | 274.49 | 0.9998 | 3.72 | 4.37 | -- | 6.30 | 14.91 | 8.27 | 19.45 | 34.50 | 34.79 | 6.30 | 12.00 | 1.24 | 10.41 | 0.0199 | -- | -3.80 | 4.82 | -3.39 | -10.70 | 35.27 | -- |
| Dishman Carbogen Amcis Ltd | 26.16bn | -1.53bn | 26.58bn | 1.30k | -- | 0.4723 | 16.88 | 1.02 | -9.79 | -9.79 | 166.66 | 358.94 | 0.2748 | 0.7081 | 4.98 | -- | -1.61 | -0.3986 | -2.09 | -0.4888 | 77.17 | 74.89 | -5.87 | -1.54 | 0.4092 | -0.1265 | 0.2913 | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
| RPG Life Sciences Limited | 5.82bn | 876.60m | 26.81bn | 1.27k | 30.59 | 7.15 | 25.60 | 4.61 | 53.00 | 53.00 | 351.92 | 226.65 | 1.25 | 1.88 | 13.45 | 4,583,071.00 | 18.81 | 16.07 | 25.10 | 21.77 | 68.30 | 62.99 | 15.06 | 11.99 | 1.50 | 246.84 | 0.00 | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
Data as of Jul 04 2024. Currency figures normalised to Borosil Scientific Ltd's reporting currency: Indian Rupee INR
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Advisors (UK) Ltd.as of 06 Jun 2024 | 85.42k | 0.00% |
| Dimensional Fund Advisors LPas of 06 Jun 2024 | 3.65k | 0.00% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
